Stephen J. Moloney
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Stephen J. Moloney
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.
18
| Subsidiary | Medical Specialties | 18 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.
9
| Extinct | Pharmaceuticals: Major | 9 |
| Public Company | Pharmaceuticals: Major | 8 | |
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen J. Moloney
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact General Counsel | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AMERICAN DG ENERGY INC | Building Products | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Medical Distributors | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| Iowa State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Concordia University | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Iowa | College/University | Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Iowa Biotechnology Association
 Iowa Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Iowa Biotechnology Association unifies Iowa''s bioscience industry, academic research institutions and economic development organizations. The firm encompasses development of industrial enzymes, livestock genetics, seed genetics, human gene research, nutraceuticals, pharmaceuticals, advanced bio-composites, biomass technologies and healthy foods/beverages. The company was founded in 1994 and is headquartered in Des Moines, IA. | Miscellaneous Commercial Services | Director/Board Member | |
| Iowa City Community School District Foundation (Iowa) | Local Agencies | Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Undergraduate Degree | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
| Richard Ivey School of Business | College/University | Masters Business Admin | |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | Advertising/Marketing Services | Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | President | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 28 |
| Kanada | 11 |
| Vereinigtes Königreich | 5 |
| Schweiz | 4 |
| Irland | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Producer Manufacturing | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 169 |
| Corporate Officer/Principal | 123 |
| Independent Dir/Board Member | 60 |
| Chief Executive Officer | 39 |
| Undergraduate Degree | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Spiegel | 30 |
| Michael Hayden | 27 |
| Richard Glickman | 26 |
| Sylvie Grégoire | 25 |
| George Milne | 24 |
| Bill Hunter | 22 |
| Dawn Svoronos | 19 |
| Suzanne Bruhn | 18 |
| Frédéric Chéreau | 17 |
| Theresa Heggie | 16 |
| J. William Freytag | 16 |
| Paul Brennan | 14 |
| Deanna M. Petersen | 14 |
| Mark Rothera | 14 |
| Søren Tulstrup | 13 |
- Börse
- Insiders
- Stephen J. Moloney
- Unternehmensverbindungen